NASDAQ:NRSN

Neurosense Therapeutics Stock News

etoro logo Buy NRSN
*Your capital is at risk
$0.465
-0.0108 (-2.27%)
At Close: Jul 31, 2026
CAMBRIDGE, Mass. , Oct. 27, 2022 /PRNewswire/ -- NeuroSense Therapeutics Ltd.
Penny stocks to buy [or avoid] after Biogen Alzheimer's news. The post 4 Alzheimer's Penny Stocks To Watch After Biogen Stock Explodes appeared first on Penny Stocks to Buy, Picks, News and Informatio
Biomarker data to be presented provide indication of PrimeC's efficacy in ALS Phase IIb PARADIGM ALS trial's primary endpoints include biomarkers and ALS-related hallmarks Topline results expected H1

Why Is NeuroSense (NRSN) Stock Up 35% Today?

10:54am, Thursday, 30'th Jun 2022
NRSN stock is on the move in the wake of encouraging clinical results for a novel drug combination to treat Alzheimer's disease. The post Why Is NeuroSense (NRSN) Stock Up 35% Today?
Penny stocks for your watch list with the stock market down today. The post 3 Penny Stocks To Watch While The Stock Market Is Down appeared first on Penny Stocks to Buy, Picks, News and Information |
NeuroSense Therapeutics Ltd (NASDAQ: NRSN) has announced results from a biomarker study to evaluate the potential of CogniC, a combination drug for Alzheimer's disease (AD). Earlier this week, Neur

3 Penny Stocks To Watch After GDP Report

10:03am, Wednesday, 29'th Jun 2022
Penny stocks to buy or avoid right now? You decide after seeing the latest updates from 3 companies.
Check these three penny stocks out right now The post Best Penny Stocks to Buy as June Ends? 3 to Watch  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
NRSN stock is getting plenty of attention today and a bid to the tune of more than 70% in the wake of positive clinical results. The post NeuroSense Therapeutics (NRSN) Stock Pops on Positive ALS Stud
Ferenc Tracik, MD to deliver presentation - "From Monotherapy to Combination Therapy: Considering a Paradigm   Shift to Target Complexity of ALS" Phase IIb ALS study for NeuroSense's combination ther
Is NeuroSense Stock A Buy, Sell, Or Hold After Jumping Up In March?
A circuit breaker is an automatic, temporary trading halt on certain securities when the underlying stock is experiencing times of high volatility. It is a measure put in place to help restore, and br
Neurosense Therapeutics Ltd (NASDAQ:NRSN) tripled market value in a day. This was after announcing approval by the US Food and Drugs Authority to advance research on a drug for Amyotrophic Lateral Scl
A thumbs up from the FDA has NRSN stock surging. Here's what this victory means for NeuroSense and for investors.
Check these three penny stocks out for your watchlist right now The post Hottest Penny Stocks To Watch as March Comes to an End  appeared first on Penny Stocks to Buy, Picks, News and Information | P
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE